Cargando…
TRIM21‑a potential biomarker for the prognosis of thyroid cancer
Thyroid cancer (THCA) is one of the commonest malignancies associated with increased recurrence. Therefore, identifying the putative molecular markers and therapeutic targets to improve the treatment of THCA is essential. The present study analyzed the potential role of tripartite motif-containing 2...
Autores principales: | Wu, Zhen, Wang, Yongkun, Yu, Zhengya, Meng, Zhen, Duan, Wenchao, Zhang, Wei, Fang, Jugao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748667/ https://www.ncbi.nlm.nih.gov/pubmed/36561971 http://dx.doi.org/10.3892/etm.2022.11697 |
Ejemplares similares
-
High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer
por: Liu, Shuang, et al.
Publicado: (2019) -
Long Non-Coding RNA LUCAT1 Promotes Progression of Thyroid Carcinoma by Reinforcing ADAM10 Expression Through Sequestering microRNA-493
por: Xiong, Guofeng, et al.
Publicado: (2020) -
PRMT5-TRIM21 interaction regulates the senescence of osteosarcoma cells by targeting the TXNIP/p21 axis
por: Li, Yu-Hang, et al.
Publicado: (2020) -
CSN6–TRIM21 axis instigates cancer stemness during tumorigenesis
por: Qin, Baifu, et al.
Publicado: (2020) -
TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC
por: von Bernuth, Amelie, et al.
Publicado: (2023)